Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Design of the ZWOT-CASE study: an observational study on the effectiveness of an integrated programme for cardiovascular risk management compared to usual care in general practice.

Marchal S, Hollander M, Schoenmakers M, Schouwink M, Timmer JR, Bilo HJG, Schwantje O, van 't Hof AWJ, Hoes AW.

BMC Fam Pract. 2019 Nov 1;20(1):149. doi: 10.1186/s12875-019-1039-z.

2.

1-Year Outcomes of Delayed Versus Immediate Intervention in Patients With Transient ST-Segment Elevation Myocardial Infarction.

Janssens GN, van der Hoeven NW, Lemkes JS, Everaars H, van de Ven PM, Marques KMJ, Nap A, van Leeuwen MAH, Appelman Y, Knaapen P, Verouden NJW, Allaart CP, Brinckman SL, Saraber CE, Plomp KJ, Timmer JR, Kedhi E, Hermanides RS, Meuwissen M, Schaap J, van der Weerdt AP, van Rossum AC, Nijveldt R, van Royen N.

JACC Cardiovasc Interv. 2019 Nov 25;12(22):2272-2282. doi: 10.1016/j.jcin.2019.07.018. Epub 2019 Sep 2.

PMID:
31488353
3.

Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group.

Hermanides RS, Kennedy MW, Kedhi E, van Dijk PR, Timmer JR, Ottervanger JP, Dambrink JH, Gosselink AM, Roolvink V, Miedema K, Slingerland RJ, Koopmans P, Bilo HJ, van 't Hof AW.

Eur Heart J Acute Cardiovasc Care. 2019 May 24:2048872619849921. doi: 10.1177/2048872619849921. [Epub ahead of print]

PMID:
31124695
4.

Does fractional flow reserve overestimate severity of LAD lesions?

Yokota S, Borren NM, Ottervanger JP, Mouden M, Timmer JR, Knollema S, Jager PL.

J Nucl Cardiol. 2019 May 1. doi: 10.1007/s12350-019-01712-0. [Epub ahead of print]

PMID:
31044405
5.

Influence of coronary calcification on hyperemic response during fractional flow reserve measurements.

Borren NM, Ottervanger JP, Mouden M, Dambrink JHE, Timmer JR, Jager PL.

Int J Cardiol. 2019 Jun 15;285:93-96. doi: 10.1016/j.ijcard.2019.02.037. Epub 2019 Feb 19.

PMID:
30857847
6.

Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.

Lemkes JS, Janssens GN, van der Hoeven NW, van de Ven PM, Marques KMJ, Nap A, van Leeuwen MAH, Appelman YEA, Knaapen P, Verouden NJW, Allaart CP, Brinckman SL, Saraber CE, Plomp KJ, Timmer JR, Kedhi E, Hermanides RS, Meuwissen M, Schaap J, van der Weerdt AP, van Rossum AC, Nijveldt R, van Royen N.

Eur Heart J. 2019 Jan 14;40(3):283-291. doi: 10.1093/eurheartj/ehy651.

PMID:
30371767
7.

Anatomically and functionally relevant coronary stenoses in patients with normal single-photon emission computed tomography but persistent stable angina.

Yokota S, Borren N, Mouden M, Timmer JR, Knollema S, Jager PL, Ottervanger JP.

Eur Heart J Cardiovasc Imaging. 2018 Dec 1;19(12):1327-1333. doi: 10.1093/ehjci/jey126.

PMID:
30247526
8.

Minimal starting time of data reconstruction for qualitative myocardial perfusion rubidium-82 positron emission tomography imaging.

van Dijk JD, Huizing ED, van Dalen JA, Timmer JR, Jager PL.

Nucl Med Commun. 2018 Jun;39(6):533-538. doi: 10.1097/MNM.0000000000000830.

PMID:
29578927
9.

Predictors of severe stenosis at invasive coronary angiography in patients with normal myocardial perfusion imaging.

Yokota S, Ottervanger JP, Mouden M, de Boer MJ, Jager PL, Timmer JR.

Neth Heart J. 2018 Apr;26(4):192-202. doi: 10.1007/s12471-018-1091-7.

10.

Coronary calcium score influences referral for invasive coronary angiography after normal myocardial perfusion SPECT.

Yokota S, Mouden M, Ottervanger JP, Engbers E, Jager PL, Timmer JR, Knollema S.

J Nucl Cardiol. 2019 Apr;26(2):602-612. doi: 10.1007/s12350-017-1067-9. Epub 2017 Sep 15.

PMID:
28916890
11.

Minimizing rubidium-82 tracer activity for relative PET myocardial perfusion imaging.

Huizing ED, van Dijk JD, van Dalen JA, Timmer JR, Arkies H, Slump CH, Jager PL.

Nucl Med Commun. 2017 Aug;38(8):708-714. doi: 10.1097/MNM.0000000000000701.

PMID:
28703721
12.

Changes in cardiovascular medication after coronary artery calcium scanning and normal single photon emission computed tomography myocardial perfusion imaging in symptomatic patients.

Engbers EM, Timmer JR, Mouden M, Knollema S, Jager PL, Ottervanger JP.

Am Heart J. 2017 Apr;186:56-62. doi: 10.1016/j.ahj.2017.01.009. Epub 2017 Jan 19.

PMID:
28454833
13.

Prognostic Value of Myocardial Perfusion Imaging with a Cadmium-Zinc-Telluride SPECT Camera in Patients Suspected of Having Coronary Artery Disease.

Engbers EM, Timmer JR, Mouden M, Knollema S, Jager PL, Ottervanger JP.

J Nucl Med. 2017 Sep;58(9):1459-1463. doi: 10.2967/jnumed.116.188516. Epub 2017 Apr 27.

14.

Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome.

Badings EA, Remkes WS, The SH, Dambrink JE, Tjeerdsma G, Rasoul S, Timmer JR, van der Wielen ML, Lok DJ, Hermanides RS, Van Wijngaarden J, Suryapranata H, van 't Hof AW.

Open Heart. 2017 Mar 2;4(1):e000538. doi: 10.1136/openhrt-2016-000538. eCollection 2017.

15.

Coronary artery calcium score as a gatekeeper in the non-invasive evaluation of suspected coronary artery disease in symptomatic patients.

Engbers EM, Timmer JR, Ottervanger JP.

J Nucl Cardiol. 2017 Jun;24(3):826-831. doi: 10.1007/s12350-017-0792-4. Epub 2017 Feb 1. No abstract available.

PMID:
28150157
16.

Impact of Gender on the Prognostic Value of Coronary Artery Calcium in Symptomatic Patients With Normal Single-Photon Emission Computed Tomography Myocardial Perfusion.

Engbers EM, Timmer JR, Ottervanger JP, Mouden M, Knollema S, Jager PL.

Am J Cardiol. 2016 Dec 1;118(11):1611-1615. doi: 10.1016/j.amjcard.2016.08.037. Epub 2016 Aug 30.

PMID:
27717443
17.

Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial.

Badings EA, Remkes WS, The SH, Dambrink JE, Tjeerdsma G, Rasoul S, Timmer JR, van der Wielen ML, Lok DJ, Hermanides R, van Wijngaarden J, Suryapranata H, van 't Hof AW.

Catheter Cardiovasc Interv. 2016 Nov;88(5):755-764. doi: 10.1002/ccd.26719. Epub 2016 Aug 27.

PMID:
27567144
18.

Prognostic Value of Coronary Artery Calcium Scoring in Addition to Single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging in Symptomatic Patients.

Engbers EM, Timmer JR, Ottervanger JP, Mouden M, Knollema S, Jager PL.

Circ Cardiovasc Imaging. 2016 May;9(5). pii: e003966. doi: 10.1161/CIRCIMAGING.115.003966.

PMID:
27165700
19.

Sequential SPECT/CT imaging starting with stress SPECT in patients with left bundle branch block suspected for coronary artery disease.

Engbers EM, Timmer JR, Mouden M, Knollema S, Jager PL, Ottervanger JP.

Eur Radiol. 2017 Jan;27(1):178-187. Epub 2016 May 11.

PMID:
27165142
20.

Visual estimation of coronary calcium on computed tomography for attenuation correction.

Engbers EM, Timmer JR, Mouden M, Jager PL, Knollema S, Oostdijk AH, Ottervanger JP.

J Cardiovasc Comput Tomogr. 2016 Jul-Aug;10(4):327-9. doi: 10.1016/j.jcct.2016.04.002. Epub 2016 Apr 11.

PMID:
27089854
21.

Timing of intervention in high-risk non-ST-elevation acute coronary syndromes in PCI versus non-PCI centres : Sub-group analysis of the ELISA-3 trial.

Badings EA, Remkes WS, Dambrink JH, The SH, Van Wijngaarden J, Tjeerdsma G, Rasoul S, Timmer JR, van der Wielen ML, Lok DJ, van 't Hof AW.

Neth Heart J. 2016 Mar;24(3):181-7. doi: 10.1007/s12471-015-0801-7.

22.

Sequential SPECT/CT imaging for detection of coronary artery disease in a large cohort: evaluation of the need for additional imaging and radiation exposure.

Engbers EM, Timmer JR, Ottervanger JP, Mouden M, Oostdijk AHJ, Knollema S, Jager PL.

J Nucl Cardiol. 2017 Feb;24(1):212-223. doi: 10.1007/s12350-015-0243-z. Epub 2015 Sep 22.

PMID:
26396025
23.

Prognostic value of normal stress-only myocardial perfusion imaging: a comparison between conventional and CZT-based SPECT.

Yokota S, Mouden M, Ottervanger JP, Engbers E, Knollema S, Timmer JR, Jager PL.

Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):296-301. doi: 10.1007/s00259-015-3192-5. Epub 2015 Sep 21.

PMID:
26392197
24.

Zero coronary calcium in the presence of three-vessel and left main coronary artery disease in a Hodgkin lymphoma survivor.

Engbers EM, Mouden M, Jager PL, Timmer JR.

Neth Heart J. 2015 Jul;23(7-8):395-8. doi: 10.1007/s12471-015-0719-0.

25.

Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy.

Demirel F, Adiyaman A, Timmer JR, Dambrink JH, Kok M, Boeve WJ, Elvan A.

Int J Cardiol. 2014 Dec 15;177(2):392-9. doi: 10.1016/j.ijcard.2014.08.132. Epub 2014 Aug 29.

PMID:
25440471
26.

Influence of proton-pump inhibitors on stomach wall uptake of 99mTc-tetrofosmin in cadmium-zinc-telluride SPECT myocardial perfusion imaging.

Mouden M, Rijkee KS, Schreuder N, Timmer JR, Jager PL.

Nucl Med Commun. 2015 Feb;36(2):143-7. doi: 10.1097/MNM.0000000000000222.

PMID:
25356621
27.

Impact of image processing in the detection of ischaemia using CZT-SPECT/CT.

Koopman D, van Dalen JA, Slump CH, Lots D, Timmer JR, Jager PL.

Nucl Med Commun. 2015 Jan;36(1):60-8. doi: 10.1097/MNM.0000000000000200.

PMID:
25203245
28.

Influence of iterative image reconstruction on CT-based calcium score measurements.

van Osch JA, Mouden M, van Dalen JA, Timmer JR, Reiffers S, Knollema S, Greuter MJ, Ottervanger JP, Jager PL.

Int J Cardiovasc Imaging. 2014 Jun;30(5):961-7. doi: 10.1007/s10554-014-0409-9. Epub 2014 Mar 28.

PMID:
24676668
29.

Prevalence, location, and extent of significant coronary artery disease in patients with normal myocardial perfusion imaging.

Yokota S, Ottervanger JP, Mouden M, Timmer JR, Knollema S, Jager PL.

J Nucl Cardiol. 2014 Apr;21(2):284-90. doi: 10.1007/s12350-013-9837-5. Epub 2014 Jan 28.

PMID:
24469846
30.

The influence of coronary calcium score on the interpretation of myocardial perfusion imaging.

Mouden M, Ottervanger JP, Timmer JR, Reiffers S, Oostdijk AH, Knollema S, Jager PL.

J Nucl Cardiol. 2014 Apr;21(2):368-74. doi: 10.1007/s12350-013-9825-9. Epub 2013 Dec 7.

PMID:
24318573
31.

Myocardial perfusion imaging with a cadmium zinc telluride-based gamma camera versus invasive fractional flow reserve.

Mouden M, Ottervanger JP, Knollema S, Timmer JR, Reiffers S, Oostdijk AH, de Boer MJ, Jager PL.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):956-62. doi: 10.1007/s00259-013-2630-5. Epub 2013 Dec 6.

PMID:
24310438
32.

Myocardial perfusion imaging in stable symptomatic patients with extensive coronary atherosclerosis.

Mouden M, Ottervanger JP, Timmer JR, Reiffers S, Oostdijk AH, Knollema S, Jager PL.

Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):136-43. doi: 10.1007/s00259-013-2539-z. Epub 2013 Aug 24.

PMID:
23974667
33.

Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: a cohort study.

Otten AM, Ottervanger JP, Timmer JR, van 't Hof AW, Dambrink JH, Gosselink AM, Hoorntje JC, Suryapranata H, Maas AH.

Diabetol Metab Syndr. 2013 Jul 4;5(1):34. doi: 10.1186/1758-5996-5-34.

34.

Clinical manifestations in ten patients with asymptomatic metal-on-metal hip arthroplasty with very high cobalt levels.

van Lingen CP, Ettema HB, Timmer JR, de Jong G, Verheyen CC.

Hip Int. 2013 Sep-Oct;23(5):441-4. doi: 10.5301/hipint.5000054. Epub 2013 Jun 28.

PMID:
23813157
35.

Coronary artery calcium scoring to exclude flow-limiting coronary artery disease in symptomatic stable patients at low or intermediate risk.

Mouden M, Timmer JR, Reiffers S, Oostdijk AH, Knollema S, Ottervanger JP, Jager PL.

Radiology. 2013 Oct;269(1):77-83. doi: 10.1148/radiol.13122529. Epub 2013 Jun 20.

PMID:
23788718
36.

Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial.

Badings EA, The SH, Dambrink JH, van Wijngaarden J, Tjeerdsma G, Rasoul S, Timmer JR, van der Wielen ML, Lok DJ, van 't Hof AW.

EuroIntervention. 2013 May 20;9(1):54-61. doi: 10.4244/EIJV9I1A9.

37.

Prevalence and predictors of bridging of coronary arteries in a large Indonesian population, as detected by 64-slice computed tomography scan.

Wirianta J, Mouden M, Ottervanger JP, Timmer JR, Juwana YB, de Boer MJ, Suryapranata H.

Neth Heart J. 2012 Oct;20(10):396-401. doi: 10.1007/s12471-012-0296-4.

38.

Impact of a new ultrafast CZT SPECT camera for myocardial perfusion imaging: fewer equivocal results and lower radiation dose.

Mouden M, Timmer JR, Ottervanger JP, Reiffers S, Oostdijk AH, Knollema S, Jager PL.

Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1048-55. doi: 10.1007/s00259-012-2086-z. Epub 2012 Mar 17.

PMID:
22426827
39.

[Hybrid cardiac SPECT-CT for coronary heart disease].

Jager PL, Mouden M, Knollema S, Timmer JR, Oostdijk AH, Ottervanger JP.

Ned Tijdschr Geneeskd. 2011;155(41):A3796. Dutch.

PMID:
22008161
40.

Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.

Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ, Dambrink JH, Bilo HJ, Zijlstra F, van 't Hof AW.

Circulation. 2011 Aug 9;124(6):704-11. doi: 10.1161/CIRCULATIONAHA.110.985911. Epub 2011 Jul 18.

PMID:
21768543
41.

Impact of diabetes on outcome in patients with non-ST-elevation myocardial infarction.

Rasoul S, Ottervanger JP, Timmer JR, Yokota S, de Boer MJ, van 't Hof AW; Zwolle myocardial infarction study group.

Eur J Intern Med. 2011 Feb;22(1):89-92. doi: 10.1016/j.ejim.2010.09.014. Epub 2010 Nov 4.

PMID:
21238901
42.

Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial.

Timmer JR, ten Berg J, Heestermans AA, Dill T, van Werkum JW, Dambrink JH, Suryapranata H, Ottervanger JP, Hamm C, van 't Hof AW; Ongoing Tirofiban In Myocardial Infarction Evaluation (On - Time) 2 study group.

EuroIntervention. 2010 Aug;6(3):336-42. doi: 10.4244/EIJV6I3A56.

PMID:
20884411
43.

Predictors of ventricular tachyarrhythmia in high-risk myocardial infarction patients treated with primary coronary intervention.

Timmer JR, Breet N, Svilaas T, Haaksma J, Van Gelder IC, Zijlstra F.

Neth Heart J. 2010 Mar;18(3):122-8.

44.

Non-bacterial thrombotic endocarditis in metastatic caecal adenocarcinoma.

Hofstra JH, Timmer JR, Breeman A, Havenith MG.

Neth Heart J. 2009 Sep;17(9):349-50. No abstract available.

45.

Hemostatic resuscitation during surgery improves survival in patients with traumatic-induced coagulopathy.

Duchesne JC, Islam TM, Stuke L, Timmer JR, Barbeau JM, Marr AB, Hunt JP, Dellavolpe JD, Wahl G, Greiffenstein P, Steeb GE, McGinness C, Baker CC, McSwain NE Jr.

J Trauma. 2009 Jul;67(1):33-7; discussion 37-9. doi: 10.1097/TA.0b013e31819adb8e.

PMID:
19590305
46.

Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.

Timmer JR, Ottervanger JP, de Boer MJ, Boersma E, Grines CL, Westerhout CM, Simes RJ, Granger CB, Zijlstra F; Primary Coronary Angioplasty vs Thrombolysis-2 Trialists Collaborators Group.

Arch Intern Med. 2007 Jul 9;167(13):1353-9.

PMID:
17620527
47.

Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMI.

Rasoul S, Ottervanger JP, Bilo HJ, Timmer JR, van 't Hof AW, Dambrink JH, Dikkeschei LD, Hoorntje JC, de Boer MJ, Zijlstra F.

Neth J Med. 2007 Mar;65(3):95-100.

48.

One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II.

Rasoul S, Ottervanger JP, Timmer JR, Svilaas T, Henriques JP, Dambrink JH, van der Horst IC, Zijlstra F.

Int J Cardiol. 2007 Oct 31;122(1):52-5. Epub 2007 Jan 16.

PMID:
17223212
49.

Long-term clinical outcome of patients with diabetes proposed for coronary revascularisation.

Timmer JR, Breeman A, Ottervanger JP, de Kluiver EP, Boonstra PW, Zijlstra F.

Neth J Med. 2006 Sep;64(8):296-301.

50.

Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy.

van der Schaaf RJ, Timmer JR, Ottervanger JP, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F, Dambrink JH.

Heart. 2006 Dec;92(12):1760-3. Epub 2006 Apr 27.

Supplemental Content

Loading ...
Support Center